HIV-1 Tat-Env complex (Tat-Env)

The Tat-Env complex is a specialized molecular assembly formed when the HIV-1 Trans-activator of transcription (Tat) protein binds to the native trimeric Envelope (Env) glycoprotein on the surface of HIV-1 virions and infected cells. This interaction, which primarily involves the V3 loop of the gp120 subunit, allows the virus to bypass canonical entry pathways and instead utilize RGD-binding integrins to infect dendritic cells, macrophages, and endothelial cells. By forming this complex, HIV-1 enhances its infectivity—particularly at low viral titers—and effectively shields the Env protein from certain neutralizing antibodies, facilitating immune evasion and the establishment of viral reservoirs. Therapeutically, the Tat-Env complex is a primary target for novel vaccine strategies, such as the Tat/Env vaccine, which aim to elicit antibodies capable of disrupting the complex and blocking viral entry. Research indicates that targeting this complex can intensify the effects of combination antiretroviral therapy (cART) by reducing residual viral replication and promoting the decay of the latent HIV reservoir. Understanding the dynamics of this complex is critical for developing functional cures and preventative measures that address the limitations of current HIV treatments.

Other names

Tat/Env complexTat-gp120 complexHIV-1 Trans-activator of transcription-Envelope glycoprotein complexTat-Env entry complex

Disruption of the Tat-Env complex to block integrin-mediated viral entry, neutralization of extracellular Tat to prevent its immunomodulatory effects, and induction of antibody-dependent cellular cytotoxicity (ADCC) against infected cells expressing the complex.